Adductor Canal Block With IPACK Versus Genicular Nerves Block With IPACK for Post-operative Analgesia

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-70
SponsorMinia University

About this trial

In our study, we will find out the efficacy of those peripheral nerve blocks on postoperative pain in knee arthroscopy.

The aim is to evaluate the efficacy of combined ultrasound-guided IPACK with adductor canal nerve block versus ultrasound-guided IPACK with genicular nerves block on postoperative pain in knee arthroscopy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

ASA l & ll

planned to undergo elective unilateral knee surgeries under spinal anesthesia

age between 20 to 70 years old

both sex

Disqualifiers

Patient refusal

Neurological deficiencies prior to surgery

Severe Cardiovascular, renal and hepatic comorbidities

Hematological disorders and abnormal coagulation parameters

Trial design

Design model

Parallel

Treatments tested in this trial

  • IPACK with adductor canal block

    Other intervention

    receive ultrasound-guided IPACK block in supine position with externally rotated leg and flexed knee, 15 ml of 0.25% plain bupivacaine then another 15 ml of 0.25% plain bupivacaine at the mid-thigh for the ACB.

  • IPACK with Genicular nerves block

    Other intervention

    receive ultrasound-guided IPACK block in supine position with externally rotated leg and flexed knee, 15 ml of 0.25% plain bupivacaine then at the anterior surface of the knee 16 ml of 0.25% plain bupivacaine divided on the 4 genicular nerves (superior medial, superior lateral, inferior medial and inferior lateral).

  • Spinal Block

    Other intervention

    won't receive any nerve block, only spinal anesthesia. \- Then spinal anesthesia will be given to all patients in the three groups, 3 ml (15 mg) 0.5% hyperbaric bupivacaine will be administered intrathecal at level of L3-4 or L4-5 interspace.

Treatment groups

72 Participants
are divided into 3 treatment groups
Group A: IA (IPACK with adductor cannal block)Active comparator 1 intervention
Group B: IG (IPACK with genicular nerves block)Active comparator 1 intervention
Group C: C (Spinal block)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

first analgesic request

the first time the patient will ask analgesia postoperative

Time frame
within 24 hours

Secondary outcomes

1

Changes in Visual Analogue Score

measuring pain intensity on a ruler with a score ranging from 0-100 mm (Weigl \& Forstner, 2021). * Dynamic: during the movement of the patient * Static: while the patient is bed ridden. * No pain: 0-4 mm * Mild pain: 5-44 mm * Moderate pain: 45-74 mm * Severe pain: 75-100 mm,

Time frame
To be measured immediately postoperative, 2h later, 4h, 6h, 8h, 12h, 18h, 24h
2

Total analgesic requirement

dose of fentanyl or paracetamol will be used postoperative

Time frame
within 24 hours
3

Time Up and Go Test (TUG)

* Ask the patient to get up from a chair * Then walk three meters, turn and return back to the chair * Finally, sit on the chair again * We calculate the time spent during the movements of the patient

Time frame
postoperative: 6h, 12h, 18h and 24h.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: